Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2.
Open Access
- 1 November 1993
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 46 (11), 1053-1054
- https://doi.org/10.1136/jcp.46.11.1053
Abstract
Serum samples from 30 patients with haemolytic uraemic syndrome (HUS), caused by Escherichia coli O157, and 30 apparently healthy volunteers, were used to examine the immune response of patients to Vero cytotoxins (VT) 1 and VT2. Patients' sera could not be differentiated from control sera using ELISA; and using immunoblotting, none of the sera had antibodies reactive with either the A or B subunits of VT1 or VT2. Examination of sera for antibodies to VT1 and VT2 seems to be of little value in the serodiagnosis of HUS caused by Vero cytotoxin-producing E coli O157.Keywords
This publication has 10 references indexed in Scilit:
- Serological identification of infection by Vero cytotoxin producing Escherichia coli in patients with haemolytic uraemic syndromeSerodiagnosis and Immunotherapy in Infectious Disease, 1990
- Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodiesInfection and Immunity, 1989
- Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndromeJournal of Clinical Microbiology, 1989
- Hemolytic uremic syndrome.1989
- Vero cytotoxin-producing strains of Escherichia coliJournal of Medical Microbiology, 1988
- Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.Journal of Biological Chemistry, 1987